InfuSystem Holdings, Inc. (NYSEMKT:INFU) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 6, 2018, Trent Smith, executive vice-president, chief accounting officer and corporate controller of InfuSystem Holdings, Inc. (the “Company”), informed the Company of his decision to resign his position with the Company effective June 15, 2018, in order to accept a position as chief financial officer of a non-public company. Mr. Smith’s resignation does not reflect any dispute or disagreement with the Company, nor does it relate to any issues with respect to the Company's financial performance. Mr. Smith has agreed to assist the Company during a transition period.
About InfuSystem Holdings, Inc. (NYSEMKT:INFU)
InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.
